PSSD
Post-SSRI sexual dysfunction, also known as post-SSRI syndrome, is a disorder in which people who have been administered selective serotonin reuptake inhibitors or other serotonin reuptake-inhibiting drugs experience persistent changes in sexual function for an extended period after ceasing to take the drug. Although the condition is most commonly associated with SRIs, similar or identical syndromes have also been reported after discontinuation of a variety of non-SRI drugs. First formally acknowledged in the medical literature in 2006, a growing body of evidence has led PSSD to slowly gain recognition by researchers and medical professionals as a distinct clinical pathology from antidepressant discontinuation syndrome and major depressive disorder.
